The Office of the Actuary (OACT) in the Centers for Medicare and Medicaid Services reports that national health spending grew by 3.9% each year from 2009 to 2011, the lowest rate of…
The FDA is doing research with the wrong audience
The US Food and Drug Administration (FDA) will move forward with a survey of healthcare professionals regarding their opinions and perceptions about prescription drug promotion after receiving approval from the…
At the heart of digital marketing is a new way to think about patients
You can throw a lot of money into digital marketing but unless you acknowledge that people using “can find shit out” and know as much as you about your product…
Is pharma prepared for more investment in digital ?
The good news is that pharma companies are planning to invest more money into digital marketing, the bad news is that pharma is planning to invest more money into digital…
Pharma not prepared for big data
The media has been talking up big data in healthcare and pharma is going to be spending more money on digital marketing and analytics but is it mostly bullshit ?…
The drug industry should bow to the inevitable
Pay for delay is a deal under which a company holding a patent on a drug pays a generic manufacturer to delay its launch of a cheap copy of the…
The real cost of pharma layoffs
If you want to know just how hard the layoffs are hitting Eli Lilly just take a glimpse at their Cafe Pharma board. There you will read of whole territories…
Bad academic study on physician detailing
The majority of family doctors receive little or no information about harmful effects of medicines when visited by drug company representatives, according to an international study involving Canadian, U.S. and…